Study of M4344 in Combination With Niraparib

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Trial withdrawn based on portfolio prioritization; oral ATRi M1774 in combination with niraparib is under investigation in DDRiver Solid Tumor 301

Conditions

Advanced Solid Tumor
Breast Cancer

Interventions

DRUG: Niraparib
DRUG: M4344
DRUG: Niraparib
DRUG: M4344
DRUG: Niraparib
DRUG: Niraparib

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]